Coronavirus Update: Lilly’s Antibody EUA Adds To ‘Turnaround’ Hopes On Pandemic

First Antibody Therapy EUA

10 Nov 2020

• By Scrip Team

Plus: Humainigen announced data from its still-blinded Phase III trial, while Korea's GeneOne advanced a DNA vaccine candidate.

Eli Lilly — Lilly is the first to gain an EUA for its antibody therapy, but Regeneron looks likely to be not far behind.

More from COVID-19

More from Scrip